Company intelligence / Profile preview

Sofia Bio

Rolle, Switzerland

Ownership: Private
Development stage: Other

Overview

SOPHiA GENETICS provides a cloud-based SaaS platform for AI-driven analysis of genomic, radiomic, and multimodal data in oncology, hereditary cancers, rare diseases, and other areas, with over 2 million genomic profiles analyzed as of March 2025.

Industry: Molecular Diagnostics

Partnerships

IlluminaQiagenAstraZenecaMemorial Sloan Kettering Cancer CenterNVIDIAMicrosoftGE HealthCareHitachiMGIElement BiosciencesInteractive Biosoftware

Beyond the preview

Go deeper on Sofia Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sofia Bio.

Explore the full profile